|
|
Article: Biotransport carriers could assist in discovery of new therapies from the human genome.(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- August 1, 2000
CopyrightCOPYRIGHT 2000 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Supratek Pharma, Inc (Montreal, Canada; 514-849-6094) announced the publication of an important paper by its scientists in the prestigious scientific journal Gene Therapy.
Oleg Romar, president and CEO stated that, "It is especially satisfying to make this announcement at the same time as the first draft of the Human Genome is published. As we have heard, this milestone is expected to herald the start of a new age in gene-based medicines and therapies. We believe that Supratek's SP1017-T Biotransport technology will have a significant role to play in successfully translating genomics information to effective gene-based medicines and therapies. In this ...
Related newspaper, magazine, and journal articles:
|
|
Article: Supratek appoints Dr. John Hooper to Board of Directors.
PR Newswire;
October 22, 2001 ;
584 words
...MONTREAL, Oct. 22 /PRNewswire/ - Supratek Pharma Inc. today announced the appointment ... industry worldwide will greatly enhance Supratek's ability to meet the challenges of ... Romar, Chairman, President and CEO of Supratek Pharma. "In addition to his outstanding ...
|
|